Pharmaceutical company Novo Nordisk has advised us that it will gradually discontinue some of its earlier generation insulin products over the next 2 years.
We recognise the vital role of insulin for people with diabetes in Australia and will work to minimise the impact of these discontinuations by providing early advice that includes alternative options.
